Methylprednisolone sodium succinate and Multiple sclerosis - a phase IV clinical study of FDA data

Summary:

Multiple sclerosis is reported as a side effect among people who take Methylprednisolone sodium succinate (methylprednisolone sodium succinate), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Benadryl, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Multiple sclerosis when taking Methylprednisolone sodium succinate. It is created by eHealthMe based on reports of 18,153 people who have side effects when taking Methylprednisolone sodium succinate from the FDA, and is updated regularly.

What is Methylprednisolone sodium succinate?

Methylprednisolone sodium succinate has active ingredients of methylprednisolone sodium succinate. eHealthMe is studying from 18,163 Methylprednisolone sodium succinate users. Check the latest studies of Methylprednisolone sodium succinate.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,084 drugs and 1,366 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 15, 2026

18,153 people reported to have side effects when taking Methylprednisolone sodium succinate.
Among them, 87 people (0.48%) have Multiple sclerosis.

Could Methylprednisolone sodium succinate cause Multiple sclerosis?

Among these 87 people:

How long have people been on Methylprednisolone sodium succinate when they have Multiple sclerosis? *

What is the gender of people who have Multiple sclerosis when taking Methylprednisolone sodium succinate? *

female: 76.62 %
male: 23.38 %

What is the age of people who have Multiple sclerosis when taking Methylprednisolone sodium succinate? *

What are other drugs people take besides Methylprednisolone sodium succinate? *

What are other side effects people have besides Multiple sclerosis? *

Weakness: 30 people, 34.48%
Feeling Abnormal: 29 people, 33.33%
Hypoaesthesia (reduced sense of touch or sensation): 27 people, 31.03%
Fatigue (feeling of tiredness): 27 people, 31.03%
Lymphocyte Count Decreased: 26 people, 29.89%
Headache (pain in head): 25 people, 28.74%
Gait Disturbance: 24 people, 27.59%
Itching: 23 people, 26.44%
Nausea (feeling of having an urge to vomit): 23 people, 26.44%
Rashes (redness): 20 people, 22.99%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 47 people, 54.02%
Sleep Disorder: 5 people, 5.75%
Chest Pain: 4 people, 4.60%
Depression: 4 people, 4.60%
Gastric Disorder (disease of stomach): 4 people, 4.60%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 3.45%
Urinary Tract Infection Bacterial: 3 people, 3.45%
Diabetes: 2 people, 2.30%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 2 people, 2.30%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 2 people, 2.30%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone sodium succinate and have Multiple sclerosis?

- Check whether Multiple sclerosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylprednisolone sodium succinate:

Methylprednisolone sodium succinate (18,163 reports)

Multiple sclerosis treatments and more:

Multiple sclerosis (799,637 reports)

How severe was Multiple sclerosis and when was it recovered:

Multiple sclerosis in Methylprednisolone sodium succinate

Expand to all the drugs that have ingredients of methylprednisolone sodium succinate:

Multiple sclerosis and drugs with ingredients of methylprednisolone sodium succinate (962 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylprednisolone sodium succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple sclerosis:

Multiple sclerosis (1,084 drugs)

Browse all the conditions that are associated with Multiple sclerosis:

Multiple sclerosis (1,366 conditions)

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone sodium succinate (the active ingredients of Methylprednisolone sodium succinate) and Methylprednisolone sodium succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.